COMMITMENTS AND CONTINGENCIES (Details Narrative)				1 Months Ended					3 Months Ended		12 Months Ended
	Jan. 01, 2024 USD ($)	Dec. 20, 2023 Integer	Aug. 01, 2023 USD ($) shares	Aug. 31, 2024 USD ($)	Apr. 30, 2022 USD ($) $ / shares shares	May 31, 2020 USD ($)	Oct. 31, 2019 USD ($)	Jul. 31, 2019 USD ($)	Mar. 31, 2025 USD ($) shares	Mar. 31, 2024 USD ($)	Dec. 31, 2025 USD ($)	Oct. 30, 2024 USD ($)	Apr. 04, 2022 $ / shares
Loss Contingencies [Line Items]
Royalty payments									$ 100,000
Royalty payments									200,000
Royalty payments									$ 300,000
Options to acquire shares | shares
Options remaining to be exercised | shares									31,013
[custom:EarnoutPayable-0]												$ 1,100,000
BIAKOS License Agreement [Member]
Loss Contingencies [Line Items]
Payment for additional royalties									$ 37,500	$ 35,000
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Royalty percentage								2.00%
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Royalty percentage								4.00%
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Maximum [Member] | Forecast [Member]
Loss Contingencies [Line Items]
Annual royalty											$ 150,000
BIAKOS Agreement [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Payment for additional royalties								$ 1,000,000
ABF License Agreement [Member]
Loss Contingencies [Line Items]
Increase in royalty annual percentage							10.00%
ABF License Agreement [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Royalty percentage							2.00%
Payment for additional royalties							$ 50,000
ABF License Agreement [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Royalty percentage							4.00%
Payment for additional royalties							$ 75,000
ABF License Agreement [Member] | Maximum [Member] | Product and Service, Other [Member]
Loss Contingencies [Line Items]
Payment for additional royalties							$ 500,000
Debrider License Agreement [Member]
Loss Contingencies [Line Items]
Increase in royalty annual percentage						10.00%
Payment of cash						$ 1,000,000
Debrider License Agreement [Member] | Rochal [Member]
Loss Contingencies [Line Items]
Payment in cash						$ 500,000
Debrider License Agreement [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Royalty percentage						2.00%
Annual royalty						$ 100,000
Debrider License Agreement [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Royalty percentage						4.00%
Annual royalty						$ 150,000
Payment for additional royalties						$ 1,000,000
Precision Healing Merger Agreement [Member]
Loss Contingencies [Line Items]
Cash consideration					$ 125,966
Payment in cash					$ 600,000
Share price | $ / shares													$ 30.75
Options to acquire shares | shares					144,191
Weighted exercise price | $ / shares					$ 10.71
Contingent consideration payments receivable					$ 10,000,000.0
Precision Healing Merger Agreement [Member] | Warrant [Member]
Loss Contingencies [Line Items]
Warrants to purchase shares | shares					4,424
Exercise price | $ / shares					$ 7.32
Expiration date					Apr. 22, 2031
Precision Healing Merger Agreement [Member] | Warrant One [Member]
Loss Contingencies [Line Items]
Warrants to purchase shares | shares					12,301
Exercise price | $ / shares					$ 12.05
Expiration date					Aug. 10, 2030
Precision Healing Merger Agreement [Member] | Accredited Investors [Member]
Loss Contingencies [Line Items]
Issuance of shares | shares					165,738
Applied Asset Purchase Agreement [Member]
Loss Contingencies [Line Items]
Assets purchase price			$ 15,250,000
Installment payable			2,500,000
Payment of installment				$ 625,000
[custom:EarnoutPayable-0]			10,000,000.0
Applied Asset Purchase Agreement [Member] | Cash Closing Consideration [Member]
Loss Contingencies [Line Items]
Cash consideration paid			$ 9,750,000
Applied Asset Purchase Agreement [Member] | Stock Closing Consideration [Member]
Loss Contingencies [Line Items]
Shares issued as consideration | shares			73,809
Value of shares issued as consideration			$ 3,000,000.0
Services Agreement [Member]
Loss Contingencies [Line Items]
Purchase agreement description			As consideration for the Petito Services, the Owner is entitled to receive: (i) a base salary of $12,000 per month during the term of the Petito Services Agreement, (ii) a royalty payment equal to three percent (3%) of the actual collections from net sales of certain products the Owner develops or codevelops that reach commercialization, (iii) a royalty payment equal to five percent (5%) for the first $50.0 million in aggregate collections from net sales of certain future products and a royalty payment of two and one-half percent (2.5%) on aggregate collections from net sales of certain future products on any amounts exceeding $50.0 million but up to $100.0 million, (iv) $500,000 in cash in the event that 510(k) clearance is issued for any future product accepted by the Company and (v) $1.0 million in cash in the event that a U.S. patent is issued for a certain product; provided that with respect to the incentive payments described in (iv) and (v) of the foregoing, the Owner shall not earn more than $2.5 million.
License Agreement [Member]
Loss Contingencies [Line Items]
Payment for additional royalties	$ 50,000
Number of unique collagen peptides | Integer		18
Outstanding units percentage		10.00%
License Agreement [Member] | Royalty Agreement Terms [Member]
Loss Contingencies [Line Items]
Payment for additional royalties	$ 100,000
License Agreement [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Royalty expense percentage		1.50%
License Agreement [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Royalty expense percentage		3.00%